ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 44 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $13,000 | +333.3% | 37,248 | +171.6% | 0.00% | – |
Q1 2020 | $3,000 | +50.0% | 13,715 | +21.6% | 0.00% | – |
Q4 2019 | $2,000 | -66.7% | 11,276 | -57.2% | 0.00% | – |
Q2 2019 | $6,000 | -14.3% | 26,352 | +81.0% | 0.00% | – |
Q1 2019 | $7,000 | -12.5% | 14,562 | -30.1% | 0.00% | – |
Q4 2018 | $8,000 | -70.4% | 20,846 | -42.5% | 0.00% | – |
Q3 2018 | $27,000 | +285.7% | 36,244 | +216.4% | 0.00% | – |
Q2 2018 | $7,000 | -50.0% | 11,455 | -44.8% | 0.00% | – |
Q4 2017 | $14,000 | +40.0% | 20,749 | +16.9% | 0.00% | -100.0% |
Q3 2017 | $10,000 | -50.0% | 17,745 | +36.7% | 0.00% | -75.0% |
Q1 2017 | $20,000 | -33.3% | 12,978 | -61.8% | 0.00% | -60.0% |
Q4 2016 | $30,000 | +76.5% | 33,986 | +167.5% | 0.01% | +66.7% |
Q3 2016 | $17,000 | – | 12,706 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 1,590,267 | $915,000 | 0.48% |
ARMISTICE CAPITAL, LLC | 4,382,000 | $2,520,000 | 0.30% |
DAFNA Capital Management LLC | 333,000 | $192,000 | 0.12% |
SABBY MANAGEMENT, LLC | 2,434,103 | $1,400,000 | 0.09% |
Anson Funds Management LP | 1,024,592 | $589,000 | 0.09% |
Hartford Financial Management Inc. | 18,000 | $10,000 | 0.01% |
Summit X, LLC | 11,000 | $7,000 | 0.01% |
SNS Financial Group, LLC | 18,000 | $10,000 | 0.00% |
DOWLING & YAHNKE LLC | 22,870 | $13,000 | 0.00% |
A.R.T. Advisors, LLC | 30,005 | $17,000 | 0.00% |